{
  "document_id": "HOUSE_OVERSIGHT_024746",
  "filename": "IMAGES-008-HOUSE_OVERSIGHT_024746.txt",
  "text": "Cannabis Investment Report | December 2017\n\nU.S. Legalized Cannabis Market: Consumer Penetration Rate\n\n25% — Path to Federal Legalization\n\nFDA Approves Cannabis-Derived Pharmaceuticals\n\n20% : More States Adopt Medical Cannabis Laws\n\nMore States Adopt Recreational Laws\n\n15% FDA Routinely Approves CBD Drugs\n\nFDA Routinely Approves THC Drugs\n\n10% — Federal Government Legalizes Cannabis\n5% -\n\n0% -\n2016 «2017 «2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030\n\nSource: Ackrell Capital\n\nMonthly Cannabis Spending\n\nWe estimated average monthly spending on cannabis using data provided by dispensaries in states with\nrecreational laws. We then assigned spending levels (low, moderate and heavy) to each age group of\neligible consumers by state. The resulting weighted averages of monthly consumer spending used in\nour analysis are as follows.\n\nU.S. Legalized Cannabis Market: Weighted Average Monthly Consumer Spending\n\n$190\n$170\n$150 7 Path to Federal Legalization\n$130 FDA Approves Cannabis-Derived Pharmaceuticals\nMore States Adopt Medical Cannabis Laws\n$110 :\nMore States Adopt Recreational Laws\n$90 1 FDA Routinely Approves CBD Drugs\nFDA Routinely Approves THC Drugs\n$70 _ = ——\nFederal Government Legalizes Cannabis\n$50\n\n2016 «2017 «2018 )§=2019 9 2020. 2021 «2022, 2023) 2024 )9=— 2025. 2026 )3=— 2027 »3= 2028 )3=— 2029 = 2030\n\nSource: Ackrell Capital\n\n110 © 2017 Ackrell Capital, LLC | Member FINRA/SIPC\n\nHOUSE_OVERSIGHT_024746",
  "metadata": {
    "original_filename": "IMAGES-008-HOUSE_OVERSIGHT_024746.txt",
    "source_dataset": "huggingface:tensonaut/EPSTEIN_FILES_20K",
    "character_count": 1446,
    "word_count": 218,
    "line_count": 53,
    "import_date": "2025-11-19T21:47:49.100873",
    "prefix": "IMAGES-008"
  }
}